PROF Valuation

Profound Medical Corp

Add to Watchlist

Advanced Chart

5.000

-0.370(-6.890%)

Overview
Forecast
Valuation

PROF Relative Valuation

PROF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PROF is overvalued; if below, it's undervalued.

Historical Valuation

Profound Medical Corp(PROF) is now in theUndervaluedzone, suggesting that its currentforward PSratio of8.71is consideredUndervaluedcompared with the five-year average of20.21.The fair price of Profound Medical Corp(PROF)is between5.19to14.11according to relative valuation methord.Compared to the current price of5.00USD, Profound Medical Corp isUndervalued By 3.59%.

Relative Value

Fair Zone

5.19-14.11

Current Price：5.00

3.59%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.49

P/B

Median3y

4.36

Median5y

4.14

-14.57

FCF Yield

Median3y

-12.93

Median5y

-10.72

Competitors Valuation Multiple

The average P/S ratio for PROF's competitors is 2.75, providing a benchmark for relative valuation. Profound Medical Corp Corp (PROF) exhibits a P/S ratio of 8.71, which is 216.54% above the industry average. Given its robust revenue growth of 63.89%, this premium appearssustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

PROF.O

Profound Medical Corp